Skip to main content

Table 4 Patients management and treatment costs and resource used for each of the health states

From: Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model

Costs attributed to health state

Progressed Disease (PD)

Progression-Free (PF)

Monthly Costs ($)

Progressed Disease (PD)

Progression-Free (PF)

GP Visit

1 visit/2 month

1 visit/2 month

1.172

1.172

Oncologist Visit

1 visit/ month

1 visit/ month

2.841

2.841

Computed Tomography

1 visit/ 3.5month

1 visit/ 3 month

2.610

3.045

Bone scintigraphy

1 visit/6.5 month

1 visit/6 month

3.467

3.756

Hospitalizations

8 days

 

147.002